Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $9.1200 (-2.04%) ($9.0700 - $9.1200) on Wed. Jul. 7, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.56% (three month average) | RSI | 35 | Latest Price | $9.1200(-2.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -1.7% a day on average for past five trading days. | Weekly Trend | FOLD declines -2.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(56%) IWO(53%) IWM(50%) XBI(50%) IWC(49%) | Factors Impacting FOLD price | FOLD will decline at least -1.28% in a week (0% probabilities). VIXM(-30%) VXX(-14%) UUP(-11%) UNG(-7%) TLT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.28% (StdDev 2.56%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.49(-83.66%) | Resistance Level | $10.07 | 5 Day Moving Average | $9.53(-4.3%) | 10 Day Moving Average | $9.85(-7.41%) | 20 Day Moving Average | $10.07(-9.43%) | To recent high | -15% | To recent low | 4.9% | Market Cap | $2.355b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |